Plasmodium falciparum histidine rich protein-2 diversity and the implications for PfHRP 2: Based malaria rapid diagnostic tests in Ghana

Malaria Journal

Volumn 15, Issue 1, 2016, Pages

  Amoah, Linda Eva ^a   Abankwa, Joana ^a   Oppong, Akua ^a  

^a University of Ghana   (Ghana)

Author keywords

Malaria diagnosis; Plasmodium falciparum; Plasmodium falciparum histidine rich protein 2 (PfHRP 2); Plasmodium falciparum histidine rich protein 3 gene (pfhrp3); Rapid diagnostic test (RDT)

Indexed keywords

AGAROSE; BACTERIAL PROTEIN; HISTIDINE RICH PROTEIN 2; HISTIDINE RICH PROTEIN 3; UNCLASSIFIED DRUG; DIAGNOSTIC KIT; HRP-2 ANTIGEN, PLASMODIUM FALCIPARUM; PARASITE ANTIGEN; PROTOZOAL DNA; PROTOZOAL PROTEIN;

ADOLESCENT; ARTICLE; BACTERIAL GENE; BLOOD SMEAR; CHILD; CONTROLLED STUDY; DIAGNOSTIC KIT; DNA EXTRACTION; DRIED BLOOD SPOT TESTING; EXON; GEL ELECTROPHORESIS; GENE AMPLIFICATION; GENE DELETION; GENETIC IDENTIFICATION; GHANA; HEALTH SURVEY; HRP2 GENE; HRP3 GENE; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MICROBIAL DIVERSITY; MICROSCOPY; NONHUMAN; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PREVALENCE; RAPID DIAGNOSTIC TEST; RAPID TEST; SCHOOL CHILD; ULTRAVIOLET RADIATION; BLOOD; GENETICS; INFANT; MALARIA, FALCIPARUM; NEWBORN; PARASITOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ANTIGENS, PROTOZOAN; CHILD; CHILD, PRESCHOOL; DNA, PROTOZOAN; GHANA; HUMANS; INFANT; INFANT, NEWBORN; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; PUBLIC HEALTH SURVEILLANCE; REAGENT KITS, DIAGNOSTIC; SEQUENCE DELETION;

EID: 84960891765     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-016-1159-z     Document Type: Article

References (29)

1. Skeet J. Malaria: its causes, treatment and methods of prevention. Nurs Times. 2005;101:43-5.
2. Bell D, Wongsrichanalai C, Barnwell JW. Ensuring quality and access for malaria diagnosis: how can it be achieved? Nat Rev Microbiol. 2006;4:682-95.
3. Makler MT, Palmer CJ, Ager AL. A review of practical techniques for the diagnosis of malaria. Ann Trop Med Parasitol. 1998;92:419-33.
4. WHO. WHO-FIND malaria RDT evaluation programme: product testing round 5. Geneva: World Health Organization; 2015.
5. WHO. Good practices for seleting and procuring rapid diagnostic tests for malaria. Geneva: World Health Organization; 2011.
6. Iqbal J, Siddique A, Jameel M, Hira PR. Persistent histidine-rich protein 2, parasite lactate dehydrogenase, and panmalarial antigen reactivity after clearance of Plasmodium falciparum monoinfection. J Clin Microbiol. 2004;42:4237-41.
7. Kumar N, Singh JP, Pande V, Mishra N, Srivastava B, Kapoor R, et al. Genetic variation in histidine rich proteins among Indian Plasmodium falciparum population: possible cause of variable sensitivity of malaria rapid diagnostic tests. Malar J. 2012;11:298.
8. Lee N, Baker J, Andrews KT, Gatton ML, Bell D, Cheng Q, et al. Effect of sequence variation in Plasmodium falciparum histidine- rich protein 2 on binding of specific monoclonal antibodies: implications for rapid diagnostic tests for malaria. J Clin Microbiol. 2006;44:2773-8.
9. Lee N, Gatton ML, Pelecanos A, Bubb M, Gonzalez I, Bell D, et al. Identification of optimal epitopes for Plasmodium falciparum rapid diagnostic tests that target histidine-rich proteins 2 and 3. J Clin Microbiol. 2012;50:1397-405.
10. WHO. Malaria rapid diagnostic test performance: summary results of WHO product testing of malaria RDTs: Rounds 1-6. (2008-2015).
11. Wurtz N, Fall B, Bui K, Pascual A, Fall M, Camara C, et al. Pfhrp2 and pfhrp3 polymorphisms in Plasmodium falciparum isolates from Dakar, Senegal: impact on rapid malaria diagnostic tests. Malar J. 2013;12:34.
12. Ho MF, Baker J, Lee N, Luchavez J, Ariey F, Nhem S, et al. Circulating antibodies against Plasmodium falciparum histidine-rich proteins 2 interfere with antigen detection by rapid diagnostic tests. Malar J. 2014;13:480.
13. Baiden F, Malm K, Bart-Plange C, Hodgson A, Chandramohan D, Webster J, et al. Shifting from presumptive to test-based management of malaria-Technical basis and implications for malaria control in Ghana. Ghana Med J. 2014;48:112-22.
14. Gerstl S, Dunkley S, Mukhtar A, De Smet M, Baker S, Maikere J. Assessment of two malaria rapid diagnostic tests in children under five years of age, with follow-up of false-positive pLDH test results, in a hyperendemic falciparum malaria area, Sierra Leone. Malar J. 2010;9:28.
15. Adu-Gyasi D, Adams M, Amoako S, Mahama E, Nsoh M, Amenga-Etego S, et al. Estimating malaria parasite density: Assumed white blood cell count of 10, 000/mul of blood is appropriate measure in Central Ghana. Malar J. 2012;11:238.
16. Ansah E, Narh-Bana S, Affran-Bonful H, Bart-Plange C, Cundill B, Gyapong M, et al. The impact of providing rapid diagnostic malaria tests on fever management in the private retail sector in Ghana: A cluster randomized trial. BMJ. 2015;350:h1019.
17. Baiden F, Webster J, Tivura M, Delimini R, Berko Y, Amenga-Etego S, et al. Accuracy of rapid tests for malaria and treatment outcomes for malaria and non-malaria cases among under-five children in rural Ghana. PLoS One. 2012;7:e34073.
18. Achaempong DO. The efficacy of rapid diagnostic test (RDT) in diagnosing Plasmodium falciparum malaria in scome selected health facilities in the Cape Coast Metropolis of Ghana. Adv Appl Sci Res. 2011;2:348-56.
19. Government of Ghana. Multiple Indicator Cluster Survey 2011. Ghana Health Service, Accra, Ghana, UNICEF, UNFPA, Japan Official Development Assistance, USAID and ICF International, Calverton, Maryland, USA Ghana, 2012.
20. Ghana Statistical Service. Population by region, district, age groups and sex. 2012.
21. Bereczky S, Martensson A, Gil JP, Farnert A. Rapid DNA extraction from archive blood spots on filter paper for genotyping of Plasmodium falciparum. Am J Trop Med Hyg. 2005;72:249-51.
22. Baidjoe A, Stone W, Ploemen I, Shagari S, Grignard L, Osoti V, et al. Combined DNA extraction and antibody elution from filter papers for the assessment of malaria transmission intensity in epidemiological studies. Malar J. 2013;12:272.
23. Baker J, McCarthy J, Gatton M, Kyle DE, Belizario V, Luchavez J, et al. Genetic diversity of Plasmodium falciparum histidine-rich protein 2 (PfHRP2) and its effect on the performance of PfHRP2-based rapid diagnostic tests. J Infect Dis. 2005;192:870-7.
24. Cheng Q, Gatton ML, Barnwell J, Chiodini P, McCarthy J, Bell D, et al. Plasmodium falciparum parasites lacking histidine-rich protein 2 and 3: A review and recommendations for accurate reporting. Malar J. 2014;13:283.
25. Gamboa D, Ho MF, Bendezu J, Torres K, Chiodini PL, Barnwell JW, et al. A large proportion of P. falciparum isolates in the Amazon region of Peru lack pfhrp2 and pfhrp3: implications for malaria rapid diagnostic tests. PLoS One. 2010;5:e8091.
26. Akinyi S, Hayden T, Gamboa D, Torres K, Bendezu J, Abdallah JF, et al. Multiple genetic origins of histidine-rich protein 2 gene deletion in Plasmodium falciparum parasites from Peru. Sci Rep. 2013;3:2797.
27. Akinyi Okoth S, Abdallah JF, Ceron N, Adhin MR, Chandrabose J, Krishnalall K, et al. Variation in Plasmodium falciparum histidine-rich protein 2 (Pfhrp2) and Plasmodium falciparum histidine-rich protein 3 (Pfhrp3) gene deletions in Guyana and Suriname. PLoS One. 2015;10:e0126805.
28. Maltha J, Gamboa D, Bendezu J, Sanchez L, Cnops L, Gillet P, et al. Rapid diagnostic tests for malaria diagnosis in the Peruvian Amazon: impact of pfhrp2 gene deletions and cross-reactions. PLoS One. 2012;7:e43094.
29. Nkrumah B, Acquah SE, Ibrahim L, May J, Brattig N, Tannich E, et al. Comparative evaluation of two rapid field tests for malaria diagnosis: partec rapid malaria test(R) and binax now(R) malaria rapid diagnostic test. BMC Infect Dis. 2011;11:143.